• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G/A filed by Addus HomeCare Corporation (Amendment)

    2/13/24 4:55:59 PM ET
    $ADUS
    Medical/Nursing Services
    Health Care
    Get the next $ADUS alert in real time by email
    SC 13G/A 1 tv0183-addushomecarecorp.htm SCHEDULE 13G/A addushomecarecorp

    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    Schedule 13G

    Under the Securities Exchange Act of 1934
    (Amendment No.: 5)*

    Name of issuer:  Addus HomeCare Corp

    Title of Class of Securities:  Common Stock

    CUSIP Number:  006739106

    Date of Event Which Requires Filing of this Statement: December 29, 2023

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

    ☒ Rule 13d-1(b)

    ☐ Rule 13d-1(c)

    ☐ Rule 13d-1(d)

    *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

    The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

    (Continued on the following page(s))

     

     

    13G

    CUSIP No.:  006739106

    1.  NAME OF REPORTING PERSON
    I.R.S. IDENTIFICATION NO. OF ABOVE PERSON

    The Vanguard Group - 23-1945930

    2.  CHECK THE APPROPRIATE [LINE] IF A MEMBER OF A GROUP

    A. 

    B.  X

    3.  SEC USE ONLY

    4.  CITIZENSHIP OF PLACE OF ORGANIZATION

    Pennsylvania

    (For questions 5-8, report the number of shares beneficially owned by each reporting person with:)

    5.  SOLE VOTING POWER

    0

    6.  SHARED VOTING POWER

    19,254

    7.  SOLE DISPOSITIVE POWER

    1,223,698

    8.  SHARED DISPOSITIVE POWER

    33,742

    9.  AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

    1,257,440

    10.  CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

    N/A

    11.  PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

    7.75%

    12.  TYPE OF REPORTING PERSON

    IA

     

     

    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    Schedule 13G
    Under the Securities Act of 1934

    Item 1(a) - Name of Issuer:

    Addus HomeCare Corp

    Item 1(b) - Address of Issuer's Principal Executive Offices:

    6303 Cowboys Way, Suite 600
    Frisco, TX 75034

    Item 2(a) - Name of Person Filing:

    The Vanguard Group - 23-1945930

    Item 2(b) – Address of Principal Business Office or, if none, residence:

    100 Vanguard Blvd.
    Malvern, PA 19355

    Item 2(c) – Citizenship:

    Pennsylvania

    Item 2(d) - Title of Class of Securities:

    Common Stock

    Item 2(e) - CUSIP Number

    006739106

    Item 3 - Type of Filing:

    This statement is being filed pursuant to Rule 13d-1.  An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E).

    Item 4 - Ownership:

      (a) Amount Beneficially Owned:

      (b) Percent of Class:

     

     

    (c)  Number of shares as to which such person has:

    (i)  sole power to vote or direct to vote:  

    (ii)  shared power to vote or direct to vote:  

    (iii)  sole power to dispose of or to direct the disposition of:  

    (iv)  shared power to dispose or to direct the disposition of:  

    Comments:

    The responses to questions 5 through 9 and 11 on the cover page(s) are incorporated by reference into this Item 4.  

    Item 5 - Ownership of Five Percent or Less of a Class:

    If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than 5 percent of the class of securities, check the following ☐

    Item 6 - Ownership of More Than Five Percent on Behalf of Another Person:

    The Vanguard Group, Inc.'s clients, including investment companies registered under the Investment Company Act of 1940 and other managed accounts, have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the securities reported herein.

    No one other person's interest in the securities reported herein is more than 5%.

    Item 7 - Identification and Classification of the Subsidiary Which Acquired The Security Being Reported on by the Parent Holding Company:

    Not applicable

    Item 8 - Identification and Classification of Members of Group:

    Not applicable

    Item 9 - Notice of Dissolution of Group:

    Not applicable

    Item 10 - Certification:

    By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under §240.14a-11.

    Signature

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

    Date:  February 13, 2024

    By /s/ Ashley Grim
    Name: Ashley Grim
    Title:  Head of Global Fund Administration

    Get the next $ADUS alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $ADUS

    DatePrice TargetRatingAnalyst
    12/16/2024$150.00Mkt Outperform
    JMP Securities
    10/11/2024$150.00Overweight
    KeyBanc Capital Markets
    6/28/2024$136.00Outperform
    Macquarie
    4/23/2024$83.00Equal Weight → Underweight
    Barclays
    3/6/2024$88.00Equal Weight
    Barclays
    2/5/2024Outperform
    William Blair
    12/12/2023$105.00Outperform
    TD Cowen
    6/29/2022$101.00Buy
    Stifel
    More analyst ratings

    $ADUS
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • JMP Securities initiated coverage on Addus HomeCare with a new price target

      JMP Securities initiated coverage of Addus HomeCare with a rating of Mkt Outperform and set a new price target of $150.00

      12/16/24 6:21:27 AM ET
      $ADUS
      Medical/Nursing Services
      Health Care
    • KeyBanc Capital Markets initiated coverage on Addus HomeCare with a new price target

      KeyBanc Capital Markets initiated coverage of Addus HomeCare with a rating of Overweight and set a new price target of $150.00

      10/11/24 7:29:16 AM ET
      $ADUS
      Medical/Nursing Services
      Health Care
    • Macquarie initiated coverage on Addus HomeCare with a new price target

      Macquarie initiated coverage of Addus HomeCare with a rating of Outperform and set a new price target of $136.00

      6/28/24 7:30:03 AM ET
      $ADUS
      Medical/Nursing Services
      Health Care

    $ADUS
    Financials

    Live finance-specific insights

    See more
    • Addus HomeCare Announces First Quarter 2025 Financial Results

      Addus HomeCare Corporation (NASDAQ:ADUS), a provider of home care services, today announced its financial results for the first quarter ended March 31, 2025. First Quarter 2025 Highlights: Net Service Revenues Grow 20.3% to $337.7 Million Net Income of $21.2 Million, or $1.16 per Diluted Share Adjusted Net Income per Diluted Share Increases 17.4% year-over-year to $1.42 Adjusted EBITDA Increases 25.1% year-over-year to $40.6 Million Cash Flow from Operations of $18.9 Million Overview Net service revenues were $337.7 million for the first quarter of 2025, a 20.3% increase compared with $280.7 million for the first quarter of 2024. Net income was $21.2 million for the first quar

      5/5/25 4:05:00 PM ET
      $ADUS
      Medical/Nursing Services
      Health Care
    • Addus HomeCare Announces First Quarter 2025 Earnings Release and Conference Call

      Addus HomeCare Corporation (NASDAQ:ADUS), a provider of home care services, announced today that it will release earnings for the first quarter ended March 31, 2025, on Monday, May 5, 2025, after the market close. Addus HomeCare will host a conference call on Tuesday, May 6, 2025, at 9:00 a.m. Eastern Time. Joining the call from the Company will be Dirk Allison, Chairman and CEO, Brian Poff, Executive Vice President and CFO, and Brad Bickham, President and COO. To access the live call, dial (833) 629-0620 (international dial-in number is (412) 317-1805) and ask to join the Addus HomeCare earnings call. A telephonic replay of the conference call will be available through midnight on May 13,

      4/21/25 11:00:00 AM ET
      $ADUS
      Medical/Nursing Services
      Health Care
    • Addus HomeCare Announces Fourth Quarter and Year End 2024 Financial Results

      Addus HomeCare Corporation (NASDAQ:ADUS), a provider of home care services, today announced its financial results for the fourth quarter and year ended December 31, 2024. Fourth Quarter 2024 Highlights: Net Service Revenues Grow 7.5% to $297.1 Million Net Income of $19.5 Million, or $1.07 per Diluted Share Adjusted Net Income per Diluted Share Increases 4.6% year-over-year to $1.38 Adjusted EBITDA Increases 10.3% year-over-year to $37.8 Million Cash Flow from Operations of $10.4 Million Completed acquisition of Gentiva personal care operations Overview Net service revenues were $297.1 million for the fourth quarter of 2024, a 7.5% increase compared with $276.4 milli

      2/24/25 4:05:00 PM ET
      $ADUS
      Medical/Nursing Services
      Health Care

    $ADUS
    Leadership Updates

    Live Leadership Updates

    See more

    $ADUS
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more

    $ADUS
    SEC Filings

    See more
    • Axonics® Announces Appointment of Dr. Esteban López to its Board of Directors

      Axonics, Inc. (NASDAQ:AXNX), a global medical technology company that is developing and commercializing novel products for the treatment of bladder and bowel dysfunction, today announced the appointment of Esteban López, M.D., MBA, to its board of directors, effective immediately. "Axonics is fortunate to have someone of Dr. López's character and extensive experience join our board of directors," said Raymond W. Cohen, CEO of Axonics. "Given his thought leadership in healthcare, Dr. López will be a valuable adviser to Axonics as we continue to execute on our ambitious growth objectives." Dr. López is the Americas healthcare and life sciences Market Lead at Google Cloud with multinational

      7/15/21 6:00:00 AM ET
      $AXNX
      $ADUS
      Medical/Dental Instruments
      Health Care
      Medical/Nursing Services
    • Addus HomeCare Announces Retirement of Laurie Manning

      Robby Stevenson Named Company's Chief Human Resource Officer Addus HomeCare Corporation (NASDAQ:ADUS), a provider of home care services, announced today that Laurie Manning retired from her position as Executive Vice President and Chief Human Resource Officer, effective June 11, 2021. Robby Stevenson, Senior Vice President of Human Resources, has been promoted to Executive Vice President and Chief Human Resource Officer and will assume leadership in that area. Commenting on the announcement, Dirk Allison, Chairman and Chief Executive Officer, said, "Laurie has played an important role in the growth and success of Addus since she joined the Company in 2017. Our employees are our most impor

      6/14/21 8:00:00 AM ET
      $ADUS
      Medical/Nursing Services
      Health Care
    • Addus HomeCare Names Veronica Hill-Milbourne And Esteban López, M.D. To Board Of Directors

      FRISCO, Texas, Jan. 11, 2021 /PRNewswire/ -- Addus HomeCare Corporation (NASDAQ: ADUS), a provider of home care services, today announced that Veronica Hill-Milbourne and Esteban López, M.D. have been appointed to the Company's Board of Directors, effective January 11, 2021. Ms. Hill-Milbourne is President and Chief Executive Officer of Spectrum Health Services, Inc., with executive oversight of three Federally Qualified Health Centers located in Philadelphia, Pennsylvania. She previously served as Chief Executive Officer/State Director for Pathways by Atar Capital, with executive oversight of mental and behavioral health home and community-based service programs operating in 30 counties

      1/11/21 8:00:00 AM ET
      $ADUS
      Medical/Nursing Services
      Health Care
    • EVP/Chief Information Officer Wattenbarger Michael D. sold $235,175 worth of shares (2,045 units at $115.00), decreasing direct ownership by 21% to 7,796 units (SEC Form 4)

      4 - Addus HomeCare Corp (0001468328) (Issuer)

      5/29/25 4:30:07 PM ET
      $ADUS
      Medical/Nursing Services
      Health Care
    • EVP/Chief Development Officer Blessing Cliff Donald sold $18,008 worth of shares (178 units at $101.17), decreasing direct ownership by 2% to 10,401 units (SEC Form 4)

      4 - Addus HomeCare Corp (0001468328) (Issuer)

      4/22/25 4:30:22 PM ET
      $ADUS
      Medical/Nursing Services
      Health Care
    • EVP/Chief Financial Officer Poff Brian was granted 31,750 shares, increasing direct ownership by 96% to 64,719 units (SEC Form 4)

      4 - Addus HomeCare Corp (0001468328) (Issuer)

      3/12/25 4:00:12 PM ET
      $ADUS
      Medical/Nursing Services
      Health Care
    • Amendment: SEC Form SCHEDULE 13G/A filed by Addus HomeCare Corporation

      SCHEDULE 13G/A - Addus HomeCare Corp (0001468328) (Subject)

      5/13/25 3:50:10 PM ET
      $ADUS
      Medical/Nursing Services
      Health Care
    • SEC Form 10-Q filed by Addus HomeCare Corporation

      10-Q - Addus HomeCare Corp (0001468328) (Filer)

      5/6/25 4:30:26 PM ET
      $ADUS
      Medical/Nursing Services
      Health Care
    • SEC Form 8-K filed by Addus HomeCare Corporation

      8-K - Addus HomeCare Corp (0001468328) (Filer)

      5/5/25 4:54:55 PM ET
      $ADUS
      Medical/Nursing Services
      Health Care

    $ADUS
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G filed by Addus HomeCare Corporation

      SC 13G - Addus HomeCare Corp (0001468328) (Subject)

      11/13/24 9:44:25 PM ET
      $ADUS
      Medical/Nursing Services
      Health Care
    • SEC Form SC 13G/A filed by Addus HomeCare Corporation (Amendment)

      SC 13G/A - Addus HomeCare Corp (0001468328) (Subject)

      2/13/24 4:55:59 PM ET
      $ADUS
      Medical/Nursing Services
      Health Care
    • SEC Form SC 13G/A filed by Addus HomeCare Corporation (Amendment)

      SC 13G/A - Addus HomeCare Corp (0001468328) (Subject)

      1/22/24 2:03:09 PM ET
      $ADUS
      Medical/Nursing Services
      Health Care

    $ADUS
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Addus HomeCare to Participate in Upcoming Investor Conferences in May

      Addus HomeCare Corporation (NASDAQ:ADUS), a provider of home care services, today announced its participation at the following investor conferences in May: BofA Securities 2025 Health Care Conference in Las Vegas, Nevada, on Wednesday, May 14, 2025. Dirk Allison, Chairman and Chief Executive Officer, Brad Bickham, President and Chief Operating Officer, and Brian Poff, Executive Vice President and Chief Financial Officer, will present at 9:20 a.m. Pacific Time / 11:20 a.m. Central Time on Wednesday, May 14, 2025. 2025 RBC Capital Markets Global Healthcare Conference in New York on Tuesday, May 20, 2025. Dirk Allison, Chairman and Chief Executive Officer and Brian Poff, Executive Vice Pr

      5/6/25 11:00:00 AM ET
      $ADUS
      Medical/Nursing Services
      Health Care
    • Addus HomeCare Announces First Quarter 2025 Financial Results

      Addus HomeCare Corporation (NASDAQ:ADUS), a provider of home care services, today announced its financial results for the first quarter ended March 31, 2025. First Quarter 2025 Highlights: Net Service Revenues Grow 20.3% to $337.7 Million Net Income of $21.2 Million, or $1.16 per Diluted Share Adjusted Net Income per Diluted Share Increases 17.4% year-over-year to $1.42 Adjusted EBITDA Increases 25.1% year-over-year to $40.6 Million Cash Flow from Operations of $18.9 Million Overview Net service revenues were $337.7 million for the first quarter of 2025, a 20.3% increase compared with $280.7 million for the first quarter of 2024. Net income was $21.2 million for the first quar

      5/5/25 4:05:00 PM ET
      $ADUS
      Medical/Nursing Services
      Health Care
    • Addus HomeCare Announces First Quarter 2025 Earnings Release and Conference Call

      Addus HomeCare Corporation (NASDAQ:ADUS), a provider of home care services, announced today that it will release earnings for the first quarter ended March 31, 2025, on Monday, May 5, 2025, after the market close. Addus HomeCare will host a conference call on Tuesday, May 6, 2025, at 9:00 a.m. Eastern Time. Joining the call from the Company will be Dirk Allison, Chairman and CEO, Brian Poff, Executive Vice President and CFO, and Brad Bickham, President and COO. To access the live call, dial (833) 629-0620 (international dial-in number is (412) 317-1805) and ask to join the Addus HomeCare earnings call. A telephonic replay of the conference call will be available through midnight on May 13,

      4/21/25 11:00:00 AM ET
      $ADUS
      Medical/Nursing Services
      Health Care